Tower Research Capital LLC (TRC) - VIVOS THERAPEUTICS INC ownership

VIVOS THERAPEUTICS INC's ticker is VVOS and the CUSIP is 92859E108. A total of 29 filers reported holding VIVOS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of VIVOS THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$12,532
+113827.3%
24,573
-26.0%
0.00%
Q1 2023$11
+57.1%
33,204
+96.2%
0.00%
Q4 2022$7
-99.9%
16,926
+27.5%
0.00%
Q3 2022$9,000
+80.0%
13,273
+279.3%
0.00%
Q2 2022$5,000
-50.0%
3,499
-8.1%
0.00%
Q1 2022$10,000
-16.7%
3,806
-30.1%
0.00%
Q4 2021$12,000
-92.1%
5,443
-85.5%
0.00%
-100.0%
Q3 2021$152,000
+7500.0%
37,631
+10181.7%
0.00%
Q1 2021$2,0003660.00%
Other shareholders
VIVOS THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Strategic Wealth Investment Group, LLC 3,219,705$1,098,2410.20%
BARD ASSOCIATES INC 201,704$68,8020.03%
PERKINS CAPITAL MANAGEMENT INC 22,500$80.01%
GODSEY & GIBB, INC 92,999$31,7220.00%
Virtu Financial LLC 46,013$160.00%
Wealth Alliance Advisory Group, LLC 17,498$5,9690.00%
Apexium Financial, LP 40,667$13,8720.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 1,308$4460.00%
GEODE CAPITAL MANAGEMENT, LLC 201,941$68,8820.00%
View complete list of VIVOS THERAPEUTICS INC shareholders